FDA Names Breakthrough Designation for Amadix’s Colon Cancer Preventative Screening Blood Test
Madrid (ots/PRNewswire) – Amadixa Spanish biotech company, today announced that PreveCol®, the blood test he developed for colon cancer, from the Food and Drug Administration (FDA) has received the designation…